KeyBank National Association’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.8M Buy
524,469
+15,960
+3% +$930K 0.12% 138
2025
Q4
$27.4M Sell
508,509
-1,845
-0.4% -$88.8K 0.1% 152
2025
Q3
$23M Sell
510,354
-47,218
-8% -$2.21M 0.08% 166
2025
Q2
$25.8M Sell
557,572
-2,026
-0.4% -$99.5K 0.1% 156
2025
Q1
$34.1M Sell
559,598
-9,299
-2% -$542K 0.14% 131
2024
Q4
$32.2M Sell
568,897
-6,788
-1% -$379K 0.12% 133
2024
Q3
$29.8M Sell
575,685
-30,595
-5% -$1.44M 0.11% 145
2024
Q2
$25.2M Sell
606,280
-55,537
-8% -$2.49M 0.1% 154
2024
Q1
$35.9M Buy
661,817
+1,594
+0.2% +$81.2K 0.15% 129
2023
Q4
$33.9M Sell
660,223
-3,099
-0.5% -$163K 0.15% 132
2023
Q3
$38.5M Sell
663,322
-19,242
-3% -$1.18M 0.18% 117
2023
Q2
$43.7M Sell
682,564
-3,266
-0.5% -$219K 0.2% 103
2023
Q1
$47.5M Sell
685,830
-4,952
-0.7% -$349K 0.23% 93
2022
Q4
$49.7M Buy
690,782
+1,286
+0.2% +$97K 0.24% 93
2022
Q3
$49M Sell
689,496
-9,523
-1% -$691K 0.26% 87
2022
Q2
$53.8M Buy
699,019
+22,257
+3% +$1.7M 0.26% 88
2022
Q1
$49.4M Sell
676,762
-12,926
-2% -$868K 0.21% 100
2021
Q4
$43M Sell
689,688
-14,182
-2% -$832K 0.17% 120
2021
Q3
$41.6M Sell
703,870
-9,397
-1% -$619K 0.18% 117
2021
Q2
$47.7M Sell
713,267
-42,528
-6% -$2.77M 0.21% 106
2021
Q1
$47.7M Buy
755,795
+5,618
+0.7% +$350K 0.22% 102
2020
Q4
$46.5M Sell
750,177
-16,955
-2% -$1.04M 0.23% 96
2020
Q3
$46.3M Sell
767,132
-17,474
-2% -$1.05M 0.25% 90
2020
Q2
$46.1M Sell
784,606
-21,868
-3% -$1.31M 0.27% 86
2020
Q1
$45M Sell
806,474
-26,731
-3% -$1.63M 0.3% 80
2019
Q4
$53.5M Buy
833,205
+159,225
+24% +$9.12M 0.29% 83
2019
Q3
$34.2M Sell
673,980
-32,857
-5% -$1.54M 0.19% 109
2019
Q2
$32.1M Sell
706,837
-15,587
-2% -$726K 0.19% 116
2019
Q1
$34.5M Sell
722,424
-17,689
-2% -$881K 0.21% 108
2018
Q4
$38.5M Sell
740,113
-27,404
-4% -$1.47M 0.25% 90
2018
Q3
$47.6M Sell
767,517
-13,892
-2% -$824K 0.26% 88
2018
Q2
$43.2M Sell
781,409
-21,281
-3% -$1.15M 0.25% 92
2018
Q1
$50.8M Sell
802,690
-5,432
-0.7% -$349K 0.3% 80
2017
Q4
$49.5M Sell
808,122
-24,100
-3% -$1.51M 0.28% 84
2017
Q3
$53M Sell
832,222
-13,155
-2% -$768K 0.31% 79
2017
Q2
$47.1M Sell
845,377
-24,070
-3% -$1.31M 0.28% 85
2017
Q1
$47.3M Sell
869,447
-35,889
-4% -$1.97M 0.28% 87
2016
Q4
$52.9M Sell
905,336
-8,966
-1% -$490K 0.33% 77
2016
Q3
$49.3M Buy
914,302
+32,435
+4% +$2.08M 0.31% 81
2016
Q2
$64.9M Sell
881,867
-18,203
-2% -$1.29M 0.42% 59
2016
Q1
$57.5M Buy
900,070
+1,652
+0.2% +$104K 0.38% 66
2015
Q4
$61.8M Sell
898,418
-7,991
-0.9% -$528K 0.42% 60
2015
Q3
$53.7M Sell
906,409
-16,913
-2% -$1.07M 0.38% 67
2015
Q2
$61.4M Sell
923,322
-11,952
-1% -$788K 0.41% 59
2015
Q1
$60.3M Sell
935,274
-10,582
-1% -$662K 0.39% 65
2014
Q4
$55.8M Sell
945,856
-14,293
-1% -$806K 0.37% 70
2014
Q3
$49.1M Sell
960,149
-21,984
-2% -$1.1M 0.34% 78
2014
Q2
$47.6M Sell
982,133
-20,029
-2% -$987K 0.32% 81
2014
Q1
$52.1M Sell
1,002,162
-4,437
-0.4% -$236K 0.4% 69
2013
Q4
$53.5M Sell
1,006,599
-14,719
-1% -$750K 0.35% 72
2013
Q3
$47.3M Sell
1,021,318
-52,197
-5% -$2.29M 0.33% 74
2013
Q2
$48M Buy
+1,073,515
New +$46.6M 0.18% 131

Other funds holding BMY

KeyBank National Association's BMY Position: Q1 2026 in Review

KeyBank National Association increased its Bristol-Myers Squibb (BMY) stake by 3.1% in Q1 2026, buying an estimated $930K and bringing the position to 524,469 shares worth $31.8M. The position accounts for 0.12% of the portfolio, ranked #138.

KeyBank National Association first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $64.9M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • KeyBank National Association held 524,469 shares of Bristol-Myers Squibb worth $31.8M as of Q1 2026.
  • KeyBank National Association bought 15,960 Bristol-Myers Squibb shares in Q1 2026, an estimated $930K.
  • Bristol-Myers Squibb made up 0.12% of KeyBank National Association's portfolio in Q1 2026, its #138 holding.
  • KeyBank National Association first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • KeyBank National Association's Bristol-Myers Squibb position peaked at $64.9M in Q2 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.